David McQuillan
Directeur Technique/Scientifique/R&D chez POLYNOVO LIMITED
Profil
David J.
McQuillan was the founder of TELA Bio, Inc. (founded in 2012) where he served as the Chief Science Officer from 2012 to 2015.
He is also the founder of ECM Technologies LLC.
Dr. McQuillan's current job(s) include being the Chief Executive Officer & Director at ECM Biosurgery, Inc., a Non-Executive Director at Cell Care Therapeutics, Inc. since 2018, a Director at Fesariustherapeutics, Inc., and the Chief Technical & Scientific Officer at Polynovo Ltd.
since 2022.
Dr. McQuillan's former job(s) include being the SVP-Advanced Research & Technology at Kinetic Concepts, Inc. from 2010 to 2011, Vice President-Research at LifeCell Corp.
from 2000 to 2012, a Senior Research Officer at the University of Melbourne from 1990 to 1994, an Associate Professor at Texas A&M University, a Member of the American Association for the Advancement of Science, and a Principal at the National Institute of Dental & Craniofacial Research from 1985 to 1989.
Dr. McQuillan's education history includes an undergraduate degree from Monash University in 1981 and a doctorate degree from Monash University in 1985.
Postes actifs de David McQuillan
| Sociétés | Poste | Début |
|---|---|---|
| POLYNOVO LIMITED | Directeur Technique/Scientifique/R&D | 01/09/2022 |
Cell Care Therapeutics, Inc.
 Cell Care Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cell Care Therapeutics, Inc. develops stem cell derived biopharmaceuticals to treat inflammatory and degenerative ophthalmic diseases. The company was founded in 2014 and is headquartered in Monrovia, CA. | Directeur/Membre du Conseil | 01/05/2018 |
ECM Technologies LLC
 ECM Technologies LLC BiotechnologyHealth Technology ECM Technologies LLC designs collagen for biomedical needs by utilizing bacterial-derived proteins as a platform. The firm''s collagens have ability to interact with cells in a manner that directs proper cell response by identifying specific cues in naturally occurring collagen that direct cellular behavior and inserting it through genetic modification into the designer collagen. The company was founded by Magnus Hook and Brooke Russell and is headquartered in Houston, TX. | Fondateur | - |
ECM Biosurgery, Inc.
 ECM Biosurgery, Inc. Packaged SoftwareTechnology Services ECM Biosurgery, Inc. develops a proprietary technology platform for bio surgery products. The private company is based in Houston, TX. The CEO of the company is David J. McQuillan. | Directeur Général | - |
Fesariustherapeutics, Inc.
 Fesariustherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Fesariustherapeutics, Inc. is an American Brooklyn-based company that specializes in tissue repair biomaterial for reconstructive surgeons. The company's flagship product, Dermisphere™, is an intelligently patterned native-state hydrogel scaffold for dermal tissue regeneration. The scaffold is made of collagen microspheres incorporated in a self-assembling collagen hydrogel that provides an optimal environment for cells from surrounding healthy tissues to migrate into the hydrogel. The company was founded by Jason Spector, a renowned plastic surgeon, and has been led by CEO Thomas G. Roueche since 2021. | Directeur/Membre du Conseil | - |
Anciens postes connus de David McQuillan
| Sociétés | Poste | Fin |
|---|---|---|
| TELA BIO, INC. | Fondateur | 01/06/2015 |
University of Melbourne
 University of Melbourne Other Consumer ServicesConsumer Services The University of Melbourne, founded in 1853, is a world-renowned institution located in Parkville, Australia. The university is a leader in education, teaching, and research, offering a wide range of coursework and research programs. | Corporate Officer/Principal | 01/01/1994 |
| National Institute of Dental & Craniofacial Research | Corporate Officer/Principal | 01/01/1989 |
| Texas A&M University | Corporate Officer/Principal | - |
| ░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ | - |
Formation de David McQuillan
| Monash University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| POLYNOVO LIMITED | Health Technology |
| TELA BIO, INC. | Health Technology |
| Entreprise privées | 8 |
|---|---|
LifeCell Corp.
 LifeCell Corp. BiotechnologyHealth Technology LifeCell Corp. develops and markets tissue repair products. The firm focuses on reconstructive, urogynecologic and orthopedic surgical procedures. Its products include alloderm, strattice, graft jacket, allocraftdbm and repliform. The company was founded in 1986 and is headquartered in Branchburg, NJ. | Health Technology |
American Association for the Advancement of Science
 American Association for the Advancement of Science Miscellaneous Commercial ServicesCommercial Services The American Association for the Advancement of Science provides science related journal, program, and education services. The firm also promotes the responsible use of science in public policy. The company was founded in 1848 and is headquartered in Washington, DC. | Commercial Services |
| National Institute of Dental & Craniofacial Research | Government |
Kinetic Concepts, Inc.
 Kinetic Concepts, Inc. Medical SpecialtiesHealth Technology Kinetic Concepts, Inc. develops advanced wound care solutions and therapies designed to deliver positive outcomes for patients and healthcare professionals. It operates business through two segments: Active Healing Solutions and LifeCell. The Active Healing Solutions segment is focused on the development and commercialization of advanced wound care therapies primarily based on its negative pressure technology platform. The LifeCell segment focuses on the development and commercialization of regenerative and reconstructive acellular tissue matrices for use in reconstructive, cosmetic, orthopedic and urogynecologic surgical procedures to repair soft tissue defects, as well as for reconstructive and cosmetic procedures. It has offices in Africa, Asia Pacific, Australia, Caribbean, Europe, Latin America, Middle East and North America. The company was founded by James R. Leininger in 1976 and is headquartered in San Antonio, TX. | Health Technology |
Cell Care Therapeutics, Inc.
Cell Care Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cell Care Therapeutics, Inc. develops stem cell derived biopharmaceuticals to treat inflammatory and degenerative ophthalmic diseases. The company was founded in 2014 and is headquartered in Monrovia, CA. | Health Technology |
ECM Technologies LLC
ECM Technologies LLC BiotechnologyHealth Technology ECM Technologies LLC designs collagen for biomedical needs by utilizing bacterial-derived proteins as a platform. The firm''s collagens have ability to interact with cells in a manner that directs proper cell response by identifying specific cues in naturally occurring collagen that direct cellular behavior and inserting it through genetic modification into the designer collagen. The company was founded by Magnus Hook and Brooke Russell and is headquartered in Houston, TX. | Health Technology |
ECM Biosurgery, Inc.
ECM Biosurgery, Inc. Packaged SoftwareTechnology Services ECM Biosurgery, Inc. develops a proprietary technology platform for bio surgery products. The private company is based in Houston, TX. The CEO of the company is David J. McQuillan. | Technology Services |
Fesariustherapeutics, Inc.
Fesariustherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Fesariustherapeutics, Inc. is an American Brooklyn-based company that specializes in tissue repair biomaterial for reconstructive surgeons. The company's flagship product, Dermisphere™, is an intelligently patterned native-state hydrogel scaffold for dermal tissue regeneration. The scaffold is made of collagen microspheres incorporated in a self-assembling collagen hydrogel that provides an optimal environment for cells from surrounding healthy tissues to migrate into the hydrogel. The company was founded by Jason Spector, a renowned plastic surgeon, and has been led by CEO Thomas G. Roueche since 2021. | Health Technology |
